AmerisourceBergen to Sell Provectus Pharmaceuticals' Pure-ific Antibacterial Hand Spray

Article

KNOXVILLE, Tenn. Provectus Pharmaceuticals, Inc. announced today that AmerisourceBergen will sell the company's first over-the-counter (OTC) product, Pure-ific Antibacterial Hand Spray. AmerisourceBergen is a leading distributor of pharmaceutical products and services to independent and chain pharmacies, as well as the hospital market, physician's offices, alternate care and mail-order facilities.

   

Pure-ific, which comes in a 1-ounce can, is designed to immediately kill up to 99.9 percent of germs on skin and prevents re-growth for up to six hours. It is packaged as a quick-drying spray, leaves no sticky residue, and is appropriate both for hands and for hard surfaces, such as toilet seats.

   

AmerisourceBergen services the Good Neighbor Pharmacy Network and the Family Pharmacy Network.  "Through our relationship with AmerisourceBergen, we

hope to grow sales throughout the 2,000-member Good Neighbor Pharmacy Network,

and then expand into the 2,500-store Family Pharmacy Network, as well," said

Timothy C. Scott, PhD, Provectus president.

   

Scott said the AmerisourceBergen agreement is significant to Provectus for

two reasons.  "First, this agreement will launch our Pure-ific sales

program into the private pharmacies market," Scott said.  "Second, the

revenues generated through Pure-ific sales will minimize our need for

additional external funding to support our core work -- clinical trials in

oncology and dermatology.  That has always been a vital part of our corporate

strategic plan to maximize shareholder value."

 

Source: Provectus Pharmaceuticals, Inc.

 

Related Videos
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Related Content